Teresa is Senior Vice President of Marketing and Market Development at Global Kinetics, where she is leading the commercialization of PKG®, an FDA cleared, CE-marked algorithm-based wearable for the assessment and interpretation of movement-based symptoms in patients with Parkinson’s Disease. Global Kinetics is committed to improving the lives of those with Parkinson’s disease with advanced medical technologies. The company was formed in 2007 to commercialize its lead product, the Personal KinetiGraph® (PKG). The PKG enables the precise monitoring, quantification, and reporting of movement symptoms in Parkinson’s. To date, Global Kinetics has supported clinical decisions for doctors who have treated more than 40,000 patients with Parkinson’s Disease, generating more than 6,000,000 hours of clinical data related to movement symptoms in Parkinson’s Disease.
Teresa has over 20 years of experience building successful, high-growth innovative health and technology brands at Boston Scientific, Bayer, Medtech Surgical (ROSA® robot), Steward Health Care, Aspect Medical, and Tenet Health, introducing multiple disruptive products into the market and leading commercial growth and expansion of ‘new to the world’ products and services. She is passionate about the need for innovation and digital health to provide better patient outcomes.
